70.81 USD
+0.88 (+1.26%)
70.81 USD
0 (0%)
We assign a fundamental rating of 6 out of 10 to CRVL. CRVL was compared to 100 industry peers in the Health Care Providers & Services industry. Both the health and profitability get an excellent rating, making CRVL a very profitable company, without any liquidiy or solvency issues. CRVL is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
CRVL had positive earnings in the past year.
CRVL had a positive operating cash flow in the past year.
In the past 5 years CRVL has always been profitable.
CRVL had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 17.22%, CRVL belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
CRVL has a better Return On Equity (29.03%) than 93.00% of its industry peers.
CRVL has a Return On Invested Capital of 28.20%. This is amongst the best in the industry. CRVL outperforms 98.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CRVL is significantly above the industry average of 9.44%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.22% | ||
| ROE | 29.03% | ||
| ROIC | 28.2% |
ROA(3y)17.02%
ROA(5y)15.59%
ROE(3y)31.06%
ROE(5y)29.09%
ROIC(3y)28.6%
ROIC(5y)26.25%
1.3 Margins
CRVL's Profit Margin of 11.28% is amongst the best of the industry. CRVL outperforms 94.00% of its industry peers.
CRVL's Profit Margin has improved in the last couple of years.
CRVL's Operating Margin of 14.49% is amongst the best of the industry. CRVL outperforms 85.00% of its industry peers.
CRVL's Operating Margin has improved in the last couple of years.
CRVL has a Gross Margin (24.20%) which is comparable to the rest of the industry.
CRVL's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.49% | ||
| PM (TTM) | 11.28% | ||
| GM | 24.2% |
OM growth 3Y1.04%
OM growth 5Y5.65%
PM growth 3Y1.12%
PM growth 5Y5.84%
GM growth 3Y-0.17%
GM growth 5Y1.95%
2. Health
2.1 Basic Checks
CRVL has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for CRVL remains at a similar level compared to 1 year ago.
CRVL has less shares outstanding than it did 5 years ago.
There is no outstanding debt for CRVL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
CRVL has an Altman-Z score of 13.49. This indicates that CRVL is financially healthy and has little risk of bankruptcy at the moment.
CRVL has a better Altman-Z score (13.49) than 98.00% of its industry peers.
CRVL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 13.49 |
ROIC/WACC3.19
WACC8.83%
2.3 Liquidity
CRVL has a Current Ratio of 1.89. This is a normal value and indicates that CRVL is financially healthy and should not expect problems in meeting its short term obligations.
CRVL has a better Current ratio (1.89) than 79.00% of its industry peers.
A Quick Ratio of 1.89 indicates that CRVL should not have too much problems paying its short term obligations.
CRVL has a better Quick ratio (1.89) than 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.89 | ||
| Quick Ratio | 1.89 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 31.77% over the past year.
The Earnings Per Share has been growing by 16.86% on average over the past years. This is quite good.
Looking at the last year, CRVL shows a quite strong growth in Revenue. The Revenue has grown by 10.43% in the last year.
The Revenue has been growing by 8.62% on average over the past years. This is quite good.
EPS 1Y (TTM)31.77%
EPS 3Y14.48%
EPS 5Y16.86%
EPS Q2Q%22.61%
Revenue 1Y (TTM)10.43%
Revenue growth 3Y11.49%
Revenue growth 5Y8.62%
Sales Q2Q%6.8%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 34.88, which means the current valuation is very expensive for CRVL.
The rest of the industry has a similar Price/Earnings ratio as CRVL.
When comparing the Price/Earnings ratio of CRVL to the average of the S&P500 Index (26.55), we can say CRVL is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.88 | ||
| Fwd PE | N/A |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as CRVL.
CRVL's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 35.86 | ||
| EV/EBITDA | 20.36 |
4.3 Compensation for Growth
CRVL has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.07
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for CRVL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
70.81
+0.88 (+1.26%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners54.77%
Inst Owner Change3.44%
Ins Owners7.09%
Ins Owner Change-0.54%
Market Cap3.63B
Revenue(TTM)933.84M
Net Income(TTM)105.33M
Analysts0
Price TargetN/A
Short Float %2.04%
Short Ratio3.59
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.88 | ||
| Fwd PE | N/A | ||
| P/S | 3.89 | ||
| P/FCF | 35.86 | ||
| P/OCF | 25.1 | ||
| P/B | 10 | ||
| P/tB | 11.15 | ||
| EV/EBITDA | 20.36 |
EPS(TTM)2.03
EY2.87%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.97
FCFY2.79%
OCF(TTM)2.82
OCFY3.98%
SpS18.22
BVpS7.08
TBVpS6.35
PEG (NY)N/A
PEG (5Y)2.07
Graham Number17.98
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.22% | ||
| ROE | 29.03% | ||
| ROCE | 35.48% | ||
| ROIC | 28.2% | ||
| ROICexc | 61.83% | ||
| ROICexgc | 78.64% | ||
| OM | 14.49% | ||
| PM (TTM) | 11.28% | ||
| GM | 24.2% | ||
| FCFM | 10.84% |
ROA(3y)17.02%
ROA(5y)15.59%
ROE(3y)31.06%
ROE(5y)29.09%
ROIC(3y)28.6%
ROIC(5y)26.25%
ROICexc(3y)48.46%
ROICexc(5y)45.93%
ROICexgc(3y)62.9%
ROICexgc(5y)61.44%
ROCE(3y)35.98%
ROCE(5y)33.03%
ROICexgc growth 3Y4.75%
ROICexgc growth 5Y18.9%
ROICexc growth 3Y6.87%
ROICexc growth 5Y18.29%
OM growth 3Y1.04%
OM growth 5Y5.65%
PM growth 3Y1.12%
PM growth 5Y5.84%
GM growth 3Y-0.17%
GM growth 5Y1.95%
F-Score8
Asset Turnover1.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 142.2% | ||
| Cap/Sales | 4.65% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 87.2% | ||
| Profit Quality | 96.07% | ||
| Current Ratio | 1.89 | ||
| Quick Ratio | 1.89 | ||
| Altman-Z | 13.49 |
F-Score8
WACC8.83%
ROIC/WACC3.19
Cap/Depr(3y)112.41%
Cap/Depr(5y)107.09%
Cap/Sales(3y)3.78%
Cap/Sales(5y)3.81%
Profit Quality(3y)90.78%
Profit Quality(5y)99.01%
High Growth Momentum
Growth
EPS 1Y (TTM)31.77%
EPS 3Y14.48%
EPS 5Y16.86%
EPS Q2Q%22.61%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)10.43%
Revenue growth 3Y11.49%
Revenue growth 5Y8.62%
Sales Q2Q%6.8%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y33.09%
EBIT growth 3Y12.65%
EBIT growth 5Y14.76%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y40.64%
FCF growth 3Y34.78%
FCF growth 5Y13.57%
OCF growth 1Y48.85%
OCF growth 3Y23.73%
OCF growth 5Y9.51%
CORVEL CORP / CRVL FAQ
What is the ChartMill fundamental rating of CORVEL CORP (CRVL) stock?
ChartMill assigns a fundamental rating of 6 / 10 to CRVL.
What is the valuation status for CRVL stock?
ChartMill assigns a valuation rating of 2 / 10 to CORVEL CORP (CRVL). This can be considered as Overvalued.
What is the profitability of CRVL stock?
CORVEL CORP (CRVL) has a profitability rating of 9 / 10.
What are the PE and PB ratios of CORVEL CORP (CRVL) stock?
The Price/Earnings (PE) ratio for CORVEL CORP (CRVL) is 34.88 and the Price/Book (PB) ratio is 10.